- Home
- NMRA vs PLYA Comparison
NMRA vs PLYA Comparison
Compare NMRA & PLYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- PLYA
- Stock Information
- Founded
- NMRA 2019
- PLYA 2006
- Country
- NMRA United States
- PLYA Netherlands
- Employees
- NMRA N/A
- PLYA N/A
- Industry
- NMRA
- PLYA Hotels/Resorts
- Sector
- NMRA
- PLYA Consumer Discretionary
- Exchange
- NMRA Nasdaq
- PLYA Nasdaq
- Market Cap
- NMRA 1.7B
- PLYA 1.5B
- IPO Year
- NMRA 2023
- PLYA N/A
- Fundamental
- Price
- NMRA $2.05
- PLYA $12.50
- Analyst Decision
- NMRA Strong Buy
- PLYA Buy
- Analyst Count
- NMRA 6
- PLYA 5
- Target Price
- NMRA $20.67
- PLYA $12.00
- AVG Volume (30 Days)
- NMRA 6.3M
- PLYA 1.2M
- Earning Date
- NMRA 03-06-2025
- PLYA 02-20-2025
- Dividend Yield
- NMRA N/A
- PLYA N/A
- EPS Growth
- NMRA N/A
- PLYA 106.66
- EPS
- NMRA N/A
- PLYA 0.49
- Revenue
- NMRA N/A
- PLYA $949,669,000.00
- Revenue This Year
- NMRA N/A
- PLYA N/A
- Revenue Next Year
- NMRA N/A
- PLYA $0.04
- P/E Ratio
- NMRA N/A
- PLYA $25.61
- Revenue Growth
- NMRA N/A
- PLYA 0.71
- 52 Week Low
- NMRA $1.83
- PLYA $6.95
- 52 Week High
- NMRA $21.00
- PLYA $12.81
- Technical
- Relative Strength Index (RSI)
- NMRA 20.26
- PLYA 67.38
- Support Level
- NMRA $2.12
- PLYA $12.10
- Resistance Level
- NMRA $2.44
- PLYA $12.56
- Average True Range (ATR)
- NMRA 0.39
- PLYA 0.30
- MACD
- NMRA -0.31
- PLYA -0.06
- Stochastic Oscillator
- NMRA 2.26
- PLYA 62.42
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About PLYA Playa Hotels & Resorts N.V.
Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company's segments are Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of HYATT ZIVA, HYATT ZILARA, Hilton, JEWEL RESORTS, and others.